Grant: Discovery Grants Program - Individual
Université Laval
$41,000.00
Next-generation viral vectors for in vivo delivery of optogenetic tools
FY 2024-25
Summary
Our ability to interrogate and modify complex biological systems has improved tremendously in recent years. This progress can largely be attributed to the development of new technologies allowing us to visualize, monitor and modify certain processes. On top of the tremendous efforts deployed to build efficient hardware, great genetically encoded strategies such as those involving CRISPR/Cas9 have propelled molecular biology into a new era. Optogenetic tools, which are genetically encoded light sensitive sensors or actuators, have changed the field of neuroscience and are expanding to other areas. These tools have increased in number and capabilities and new needs related to their use have emerged since they appeared over a decade ago. One of the remaining challenges when using these tools is in vivo delivery. The vehicle by which the tool is delivered must be efficiently assembled and processed, minimally invasive, compatible with mammalian immune systems and able to target the appropriate structure or cell type. Viral vectors based on recombinant adeno-associated viruses (rAAV) have proven very useful gene delivery vehicles as they are not pathogenic, establish long-term gene expression and can be used in vivo. Their ability to infect non-dividing cells such as neurons, has made them the vector of choice in neuroscience. Combining an extensive experience in molecular and cellular biology together with viral vector manufacturing, my research program focuses on the development of innovative strategies for the delivery and utilization of optogenetic tools. Three main lines of research will be pursued: 1) The identification of new native AAVs from environmental samples, their characterization and comparison to existing serotypes, and their exploitation as potential vehicles for gene transfer 2) The investigation and optimisation of native and engineered AAV transduction mechanisms 3) The engineering of AAV based strategies for efficient targeting of the central nervous system in translationally relevant species.
Program
Discovery Grants Program - Individual
Recipient
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data
As published
Application id
RGPIN-2024-05828
Name nom
Paquet, Marie-Eve
Department département
Biochimie, microbiologie et bioinformatique
Organization id
51
Institution établissement
Université Laval
Province en
Québec
Province fr
Québec
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2024
Competition year année de concours
2024
Award amount
41000
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
DISCOVERY RESEARCH
Group fr
RECHERCHE AXÉE SUR LA DÉCOUVERTE
Committee code
1501
Committee name en
Genes, Cells and Molecules
Committee name fr
Gènes, cellules et molécules
Area of application code
1201
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Life sciences (including biotechnology)
Area of application fr
Sciences de la vie (y compris biotechnologie)
Research subject code
5305
Research subject group en
Molecular biology
Research subject group fr
Biologie moléculaire
Research subject en
Protein manipulation and expression
Research subject fr
Expression et recombinaison protéiques
Field of research list names en
Not available
Field of research list names fr
Non disponible
Socioeconomic objective list names en
Not available
Socioeconomic objective list names fr
Non disponible
Application title
Next-generation viral vectors for in vivo delivery of optogenetic tools
Keywords
virology; adeno associated virus; gene transfer; advanced optical imaging; optogenetics; molecular biology; capsid modification; virus engineering; intracellular trafficking; environmental microbiology
Application summary
Our ability to interrogate and modify complex biological systems has improved tremendously in recent years. This progress can largely be attributed to the development of new technologies allowing us to visualize, monitor and modify certain processes. On top of the tremendous efforts deployed to build efficient hardware, great genetically encoded strategies such as those involving CRISPR/Cas9 have propelled molecular biology into a new era. Optogenetic tools, which are genetically encoded light sensitive sensors or actuators, have changed the field of neuroscience and are expanding to other areas. These tools have increased in number and capabilities and new needs related to their use have emerged since they appeared over a decade ago. One of the remaining challenges when using these tools is in vivo delivery. The vehicle by which the tool is delivered must be efficiently assembled and processed, minimally invasive, compatible with mammalian immune systems and able to target the appropriate structure or cell type. Viral vectors based on recombinant adeno-associated viruses (rAAV) have proven very useful gene delivery vehicles as they are not pathogenic, establish long-term gene expression and can be used in vivo. Their ability to infect non-dividing cells such as neurons, has made them the vector of choice in neuroscience. Combining an extensive experience in molecular and cellular biology together with viral vector manufacturing, my research program focuses on the development of innovative strategies for the delivery and utilization of optogenetic tools. Three main lines of research will be pursued: 1) The identification of new native AAVs from environmental samples, their characterization and comparison to existing serotypes, and their exploitation as potential vehicles for gene transfer 2) The investigation and optimisation of native and engineered AAV transduction mechanisms 3) The engineering of AAV based strategies for efficient targeting of the central nervous system in translationally relevant species.